New Insights into the Management and Therapeutics of Type 2 Diabetes

  title={New Insights into the Management and Therapeutics of Type 2 Diabetes},
  author={A. Gangawane},
Type 2 Diabetes is Insulin dependent diabetes caused due to decrease in the production and secretion of Insulin or resistance to insulin. There may be multiple factors underlying the pathophysiology of the disease, however, maintaining required insulin levels in response to glucose stimulation has been the precise for diverse treatment modalities. With widely used three tier anti-hyperglycemic therapy regimes comprising of monotherapy, dual therapy and triple therapy being unable to avoid… Expand

Figures and Topics from this paper


Incretin‐based drugs for type 2 diabetes: Focus on East Asian perspectives
  • 111
Novel therapy for insulin-dependent diabetes mellitus: infusion of in vitro-generated insulin-secreting cells
  • 28
Clinical Efficacy of Stem Cell Therapy for Diabetes Mellitus: A Meta-Analysis
  • 57
  • PDF
Alpha-glucosidase inhibitors for people with impaired glucose tolerance or impaired fasting blood glucose.
  • 115
  • PDF
Therapeutic potential of human embryonic stem cells in type 2 diabetes mellitus.
  • G. Shroff
  • Medicine
  • World journal of stem cells
  • 2016
  • 11
Treatment progression in sulfonylurea and dipeptidyl peptidase-4 inhibitor cohorts of type 2 diabetes patients on metformin
  • 1
  • PDF
Common medications used by patients with type 2 diabetes mellitus: what are their effects on the lipid profile?
  • 36
Standards of Medical Care in Diabetes—2011
  • 2,706
  • PDF